$MYGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MYRIAD GENETICS INC. Get notifications about new insider transactions in MYRIAD GENETICS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 23 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 30.59 | 3,196 | 97,775 | 17,735 | 20.9 K to 17.7 K (-15.27 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 8.63 | 3,196 | 27,581 | 20,931 | 17.7 K to 20.9 K (+18.02 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 5.89 | 20,000 | 117,800 | 20,000 | |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 30.59 | 20,000 | 611,874 | 84,225 | 104.2 K to 84.2 K (-19.19 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 5.89 | 20,000 | 117,800 | 104,225 | 84.2 K to 104.2 K (+23.75 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 12.17 | 21,192 | 257,907 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 28.75 | 21,192 | 609,270 | 48,268 | 69.5 K to 48.3 K (-30.51 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 12.17 | 21,192 | 257,907 | 69,460 | 48.3 K to 69.5 K (+43.90 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 28.75 | 5,808 | 166,980 | 48,268 | 54.1 K to 48.3 K (-10.74 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 12.17 | 5,808 | 70,683 | 54,076 | 48.3 K to 54.1 K (+12.03 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Gift | G | 0.00 | 1,000 | 0 | 48,268 | 49.3 K to 48.3 K (-2.03 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 13.28 | 62,176 | 825,697 | 0 | |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 29.91 | 62,176 | 1,859,796 | 48,268 | 110.4 K to 48.3 K (-56.30 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 13.28 | 62,176 | 825,697 | 110,444 | 48.3 K to 110.4 K (+128.81 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 5.89 | 25,000 | 147,250 | 40,000 | |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 5.89 | 25,000 | 147,250 | 65,000 | |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 29.91 | 25,000 | 747,838 | 84,225 | 109.2 K to 84.2 K (-22.89 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 5.89 | 25,000 | 147,250 | 109,225 | 84.2 K to 109.2 K (+29.68 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 29.71 | 25,000 | 742,793 | 84,225 | 109.2 K to 84.2 K (-22.89 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 5.89 | 25,000 | 147,250 | 109,225 | 84.2 K to 109.2 K (+29.68 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 18.06 | 12,770 | 230,626 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 13.28 | 20,676 | 274,577 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 5.89 | 5,000 | 29,450 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.05 | 20,676 | 621,252 | 6,657 | 27.3 K to 6.7 K (-75.64 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 13.28 | 20,676 | 274,577 | 27,333 | 6.7 K to 27.3 K (+310.59 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.05 | 12,770 | 383,700 | 6,657 | 19.4 K to 6.7 K (-65.73 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 18.06 | 12,770 | 230,626 | 19,427 | 6.7 K to 19.4 K (+191.83 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.05 | 5,000 | 150,235 | 6,657 | 11.7 K to 6.7 K (-42.89 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 5.89 | 5,000 | 29,450 | 11,657 | 6.7 K to 11.7 K (+75.11 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 7.82 | 16,782 | 131,235 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 7.82 | 13,100 | 102,442 | 16,782 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 31.00 | 16,782 | 520,259 | 17,735 | 34.5 K to 17.7 K (-48.62 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 7.82 | 16,782 | 131,235 | 34,517 | 17.7 K to 34.5 K (+94.63 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 29.68 | 13,100 | 388,815 | 17,735 | 30.8 K to 17.7 K (-42.48 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 7.82 | 13,100 | 102,442 | 30,835 | 17.7 K to 30.8 K (+73.87 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 8.63 | 41,804 | 360,769 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 7.27 | 21,096 | 153,368 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 29.05 | 41,804 | 1,214,243 | 24,029 | 65.8 K to 24 K (-63.50 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 8.63 | 41,804 | 360,769 | 65,833 | 24 K to 65.8 K (+173.97 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 29.05 | 21,096 | 612,757 | 24,029 | 45.1 K to 24 K (-46.75 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 7.27 | 21,096 | 153,368 | 45,125 | 24 K to 45.1 K (+87.79 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 6.00 | 18,218 | 109,308 | 11,784 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 29.61 | 18,218 | 539,364 | 84,225 | 102.4 K to 84.2 K (-17.78 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 6.00 | 18,218 | 109,308 | 102,443 | 84.2 K to 102.4 K (+21.63 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 35,000 | 0 | 84,225 | 119.2 K to 84.2 K (-29.36 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 33,000 | 0 | 119,225 | 152.2 K to 119.2 K (-21.68 %) |
| Oct 24 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Oct 24 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
| Oct 24 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 13.28 | 5,324 | 70,703 | 24,029 | 18.7 K to 24 K (+28.46 %) |
| Oct 24 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 12.17 | 5,808 | 70,683 | 18,705 | 12.9 K to 18.7 K (+45.03 %) |
| Oct 09 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 7.82 | 3,900 | 30,498 | 29,882 | |
| Oct 09 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 28.50 | 3,900 | 111,150 | 17,735 | 21.6 K to 17.7 K (-18.03 %) |
| Oct 09 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 7.82 | 3,900 | 30,498 | 21,635 | 17.7 K to 21.6 K (+21.99 %) |
| Oct 04 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 7.82 | 3,000 | 23,460 | 33,782 | |
| Oct 04 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 28.50 | 3,000 | 85,500 | 17,735 | 20.7 K to 17.7 K (-14.47 %) |
| Oct 04 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 7.82 | 3,000 | 23,460 | 20,735 | 17.7 K to 20.7 K (+16.92 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 3,792 | 22,335 | 0 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 30,630 | 180,411 | 3,792 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 5.89 | 578 | 3,404 | 0 | |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 3,792 | 106,414 | 46,771 | 50.6 K to 46.8 K (-7.50 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 3,792 | 22,335 | 50,563 | 46.8 K to 50.6 K (+8.11 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 30,630 | 859,561 | 46,771 | 77.4 K to 46.8 K (-39.57 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 30,630 | 180,411 | 77,401 | 46.8 K to 77.4 K (+65.49 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 28.06 | 578 | 16,220 | 46,771 | 47.3 K to 46.8 K (-1.22 %) |
| Oct 03 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 5.89 | 578 | 3,404 | 47,349 | 46.8 K to 47.3 K (+1.24 %) |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 4.44 | 26,250 | 116,550 | 0 | |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.99 | 26,250 | 708,396 | 46,771 | 73 K to 46.8 K (-35.95 %) |
| Sep 28 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 4.44 | 26,250 | 116,550 | 73,021 | 46.8 K to 73 K (+56.12 %) |
| Sep 19 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 28.00 | 5,000 | 140,000 | 17,735 | 22.7 K to 17.7 K (-21.99 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 27.07 | 130,000 | 3,519,100 | 130,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 27.07 | 69,407 | 1,878,847 | 69,407 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | A | 27.07 | 593 | 16,053 | 593 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | A | 27.07 | 69,407 | 1,878,847 | 69,407 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | A | 27.07 | 593 | 16,053 | 593 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | A | 27.07 | 190,000 | 5,143,300 | 190,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 5,494 | 20,877 | 0 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 27.10 | 5,494 | 148,887 | 46,771 | 52.3 K to 46.8 K (-10.51 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 5,494 | 20,877 | 52,265 | 46.8 K to 52.3 K (+11.75 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | A | 27.07 | 160,000 | 4,331,200 | 160,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 27.07 | 300,000 | 8,121,000 | 300,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | A | 27.07 | 180,000 | 4,872,600 | 180,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 2,952 | 0 | 12,897 | 15.8 K to 12.9 K (-18.63 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | A | 27.07 | 520,000 | 14,076,400 | 520,000 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 6.00 | 20,000 | 120,000 | 30,002 | |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 27.60 | 20,000 | 552,008 | 152,225 | 172.2 K to 152.2 K (-11.61 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 6.00 | 20,000 | 120,000 | 172,225 | 152.2 K to 172.2 K (+13.14 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | BENSON T CRAIG | President, Myriad R ... | Option Exercise | A | 27.07 | 100,000 | 2,707,000 | 100,000 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 10,091 | 38,346 | 5,494 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 5,316 | 20,201 | 15,585 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 1,597 | 6,069 | 20,901 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 3.80 | 7,502 | 28,508 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 27.08 | 10,091 | 273,257 | 46,771 | 56.9 K to 46.8 K (-17.75 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 10,091 | 38,346 | 56,862 | 46.8 K to 56.9 K (+21.58 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.97 | 5,316 | 143,378 | 46,771 | 52.1 K to 46.8 K (-10.21 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 5,316 | 20,201 | 52,087 | 46.8 K to 52.1 K (+11.37 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.95 | 1,597 | 43,039 | 46,771 | 48.4 K to 46.8 K (-3.30 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 1,597 | 6,069 | 48,368 | 46.8 K to 48.4 K (+3.41 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.95 | 7,502 | 202,180 | 46,771 | 54.3 K to 46.8 K (-13.82 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 3.80 | 7,502 | 28,508 | 54,273 | 46.8 K to 54.3 K (+16.04 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 14,104 | 127,500 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 1,251 | 11,309 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 8.63 | 4,450 | 38,404 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 14,104 | 380,808 | 49,268 | 63.4 K to 49.3 K (-22.26 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 14,104 | 127,500 | 63,372 | 49.3 K to 63.4 K (+28.63 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 1,251 | 33,777 | 49,268 | 50.5 K to 49.3 K (-2.48 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 1,251 | 11,309 | 50,519 | 49.3 K to 50.5 K (+2.54 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 4,450 | 120,150 | 49,268 | 53.7 K to 49.3 K (-8.28 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 8.63 | 4,450 | 38,404 | 53,718 | 49.3 K to 53.7 K (+9.03 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 7.82 | 8,981 | 70,231 | 20,960 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 7.82 | 10,319 | 80,695 | 29,941 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 27.00 | 8,981 | 242,501 | 15,849 | 24.8 K to 15.8 K (-36.17 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 7.82 | 8,981 | 70,231 | 24,830 | 15.8 K to 24.8 K (+56.67 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 27.00 | 10,319 | 278,613 | 15,849 | 26.2 K to 15.8 K (-39.43 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 7.82 | 10,319 | 80,695 | 26,168 | 15.8 K to 26.2 K (+65.11 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 6.00 | 19,998 | 119,988 | 50,002 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 4.44 | 2 | 9 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 26.92 | 2 | 54 | 152,225 | 152.2 K to 152.2 K (0.00 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 4.44 | 2 | 9 | 152,227 | 152.2 K to 152.2 K (0.00 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 26.92 | 19,998 | 538,438 | 152,225 | 172.2 K to 152.2 K (-11.61 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 6.00 | 19,998 | 119,988 | 172,223 | 152.2 K to 172.2 K (+13.14 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 34,000 | 0 | 152,225 | 186.2 K to 152.2 K (-18.26 %) |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 16.46 | 17,198 | 283,079 | 0 | |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 16.46 | 12,802 | 210,721 | 17,198 | |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 10.60 | 20,000 | 212,000 | 0 | |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 7.60 | 10,000 | 76,000 | 0 | |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 26.10 | 17,198 | 448,820 | 0 | 17.2 K to 0 (-100.00 %) |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 16.46 | 17,198 | 283,079 | 17,198 | 0 to 17.2 K |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 25.94 | 12,802 | 332,115 | 0 | 12.8 K to 0 (-100.00 %) |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 16.46 | 12,802 | 210,721 | 12,802 | 0 to 12.8 K |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 25.94 | 20,000 | 518,848 | 0 | 20 K to 0 (-100.00 %) |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 10.60 | 20,000 | 212,000 | 20,000 | 0 to 20 K |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 25.94 | 10,000 | 259,424 | 0 | 10 K to 0 (-100.00 %) |
| Aug 21 2012 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 7.60 | 10,000 | 76,000 | 10,000 | 0 to 10 K |
| Aug 03 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Aug 03 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 13.28 | 5,324 | 70,703 | 186,225 | 180.9 K to 186.2 K (+2.94 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 340 | 2,951 | 0 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 15,056 | 130,686 | 340 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.68 | 4 | 35 | 0 | |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 4 | 104 | 46,771 | 46.8 K to 46.8 K (-0.01 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 4 | 35 | 46,775 | 46.8 K to 46.8 K (+0.01 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 340 | 8,845 | 46,771 | 47.1 K to 46.8 K (-0.72 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 340 | 2,951 | 47,111 | 46.8 K to 47.1 K (+0.73 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 26.01 | 15,056 | 391,656 | 46,771 | 61.8 K to 46.8 K (-24.35 %) |
| Jul 18 2012 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.68 | 15,056 | 130,686 | 61,827 | 46.8 K to 61.8 K (+32.19 %) |
| Jul 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 8.68 | 1,478 | 12,829 | 0 | |
| Jul 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 25.90 | 1,478 | 38,280 | 180,901 | 182.4 K to 180.9 K (-0.81 %) |
| Jul 13 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 8.68 | 1,478 | 12,829 | 182,379 | 180.9 K to 182.4 K (+0.82 %) |
| Jul 11 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 8.68 | 8,522 | 73,971 | 1,478 | |
| Jul 11 2012 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 8.68 | 20,000 | 173,600 | 10,000 |